|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o ActiveSight, of San Diego, entered a second protein crystallography services agreement with Lexicon Pharmaceuticals Inc., of Princeton, N.J. The agreement extends the co-crystallography of Lexicon's small-molecule compounds to a second human drug target protein validated in vivo by Lexicon and expressed by ActiveSight.
o Acusphere Inc., of Watertown, Mass., said a research paper on the company's Hydrophobic Drug Delivery Systems was published in March in Pharmaceutical Research. It highlighted a formulation of paclitaxel, called AI-850, which uses intravenous hydrophobic drug delivery. The technology showed that it can produce high concentrations of drug in ...